# Mind and Skin - the Neurocutaneous Axis in Atopic Eczema

> **NCT05790330** · — · RECRUITING · sponsor: **King's College London** · enrollment: 90 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT05790330
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-10
- **Primary completion:** 2025-12-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05790330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05790330, "Mind and Skin - the Neurocutaneous Axis in Atopic Eczema". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05790330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*